ARVINDFASN.BO(ARVINDFASN.BO)
ARVINDFASN.BO
No analyst ratings available
No analyst price targets available for ARVINDFASN.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $59.35B | $66.86B | $72.02B |
| Low | $58.81B | $65.45B | $71.16B |
| High | $60.45B | $68.25B | $72.89B |
| EBITDA Avg | $11.00B | $12.39B | $13.35B |
| Low | $10.90B | $12.13B | $13.19B |
| High | $11.20B | $12.65B | $13.51B |
| EBIT Avg | $8.71B | $9.81B | $10.57B |
| Low | $8.63B | $9.60B | $10.44B |
| High | $8.87B | $10.01B | $10.69B |
| Net Income Avg | $1.94B | $2.58B | $2.59B |
| Low | $1.39B | $1.96B | $2.53B |
| High | $2.09B | $2.84B | $2.65B |
| EPS Avg | $12.81 | $17.59 | $19.30 |
| Low | $10.39 | $14.67 | $18.91 |
| High | $15.63 | $21.22 | $19.79 |
| Analysts (Rev / EPS) | 7 / 6 | 7 / 7 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|---|
| Revenue Avg | $12.44B | $15.92B | $15.46B | $15.33B |
| Low | $12.44B | $15.92B | $15.46B | $15.33B |
| High | $12.44B | $15.92B | $15.46B | $15.33B |
| EBITDA Avg | $2.31B | $2.95B | $2.87B | $2.84B |
| Low | $2.31B | $2.95B | $2.87B | $2.84B |
| High | $2.31B | $2.95B | $2.87B | $2.84B |
| EBIT Avg | $1.82B | $2.34B | $2.27B | $2.25B |
| Low | $1.82B | $2.34B | $2.27B | $2.25B |
| High | $1.82B | $2.34B | $2.27B | $2.25B |
| Net Income Avg | $214M | $696M | $816M | $883M |
| Low | $214M | $696M | $816M | $883M |
| High | $214M | $696M | $816M | $883M |
| EPS Avg | $1.60 | $5.20 | $6.10 | $6.60 |
| Low | $1.60 | $5.20 | $6.10 | $6.60 |
| High | $1.60 | $5.20 | $6.10 | $6.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |